Cooley Represents Life Sciences Company in SEC and DOJ Insider Trading Inquiries

Successfully represented a leading Seattle-based life sciences company in response to SEC and DOJ inquiries regarding insider trading prior to the company's announcement of clinical trial results.

Related Contacts
Christopher B. Durbin Partner, Seattle
Related Practices & Industries

Securities Litigation